PATENT CLAIM ANALYSIS

Application Number: 16221390
Application Type: Utility
Filing Date: 2018-12
Publication Date: 2019-06
Patent Classification: ["514", "378000"]

Abstract:
Disclosed herein are methods for treating or preventing ophthalmic and dermatologic conditions in a patient, including ocular surface conditions such as blepharitis. The methods can include topically administering directly to an ocular surface of one or more eyes of a patient in need of treatment thereof an effective amount of an isoxazoline parasiticide, formamidine parasiticide, or other active ingredient, formulated into an ophthalmic composition, the ophthalmic composition further comprising a pharmaceutically acceptable vehicle. Compositions are also disclosed.

Claim (Index 19):
The method of  claim 18 , further comprising receiving a first assessment of a quantity of  Demodex  mites on an anatomical structure of the patient, and topically administering the ophthalmic composition if the quantity of  Demodex  mites is greater than a predetermined value.

Metadata:
- Claim Count in Document: 42.0
- Percentile: 98.0
- Lexical Diversity: 1.46552
- Patent Class: 514.0
- Transitional Phrase Type: open
- Component Type: 1
- Foreign Priority: False
- Related Applications: ['11846961', '13181767', '14133780', '13856638', '12771705']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7493664290837576
- 35 USC 102 Novelty (BERT): 0.5311763078416949
- Combined Prediction Score: 0.7275474169595514
- Mean Citation Score: 225.158708
- Max Citation Score: 237.24426
- Similarity Product: 159.5505014308047

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 0
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test